Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

LEBER'S DISEASE WITH SYMPTOMS RESEMBLING DISSEMINATED SCLEROSIS.
[Olfactory dysfonction in multiple sclerosis: role for subventricular zone progenitors].
The utility of the Six-Spot Step Test as a measure of walking performance in ambulatory individuals with Multiple Sclerosis across the disability spectrum.
Structural Brain MR Imaging Changes Associated with Obsessive-Compulsive Disorder in Patients with Multiple Sclerosis.
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters.
Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.
Decade in review-multiple sclerosis: New drugs and personalized medicine for multiple sclerosis.
Psychosocial, Affective, and Behavioral Consequences of Multiple SclerosisTreatment of the "Whole" Patient.
Upper extremity function and its relation with hand sensation and upper extremity strength in patients with multiple sclerosis.
Neuro-ophthalmologic evaluation, quality of life, and functional disability in patients with MS.
Emotional and neutral verbal memory impairment in Multiple Sclerosis.
Multiple deep white matter lesions mimic multiple sclerosis as an unusual complication of left atrial myxoma.
[Ginkgolide B promotes axonal growth of retina ganglion cells by anti-apoptosis in vitro].
Low serum urate levels are associated to female gender in multiple sclerosis patients.
Blood-Brain Barrier Alterations in the Cerebral Cortex in Experimental Autoimmune Encephalomyelitis.
Multiple neurological abnormalities, including pontine hemorrhage, multiple sclerosis and aseptic meningitis, during anti-TNF-α therapy in psoriatic arthritis.
Onabotulinum toxin A for the treatment of neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis.
Aggregation of MBP in chronic demyelination.
Advanced MRI in multiple sclerosis: current status and future challenges.
The Effect of Culture on Two Information-Processing Speed Tests.
Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders.
Severe multiple sclerosis reactivation under fingolimod 3 months after natalizumab withdrawal.
A TSPO ligand is protective in a mouse model of multiple sclerosis.
Fingolimod-associated amenorrhea: a report of three cases.
Clinical Improvement after Extracranial Venoplasty in Multiple Sclerosis.

Pages